BMRN | BioMarin Pharmaceutical Inc
Category: Consumer goods
Quick infos Headquarters: Novato, California, United States Trade prices Volume: Market Cap: 14.00B Prev closed: 75.1 Open: 74.79 High: 76.53 Low: 74.6 52 week low: 71.35 52 week high: 121.23 Dividends: No Dividends Next ER: July 28, 2021 After Market Closes
About the Company BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies.
Earnings History Date EPS / Forecast Revenue / Forecast October 28, 2021 July 28, 2021 0.07 / -0.1093501.7M / 447.6MBeat! April 29, 2021 0.09 / -0.0892486M / 446.35MBeat! February 25, 2021 0.12 / -0.1681452.1M / 439.33MBeat! November 5, 2020 4.01 / 0.25476.8M / 457.38MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Sep 17, 2021 77.76 76.63 77.95
76.47
2.95M 1.65% Sep 16, 2021 76.50 76.65 77.30
75.82
795.38K -1% Sep 15, 2021 77.27 76.90 77.43
76.00
1.24M 1.44% Sep 14, 2021 76.17 78.50 78.69
76.10
791.03K -2.32% Sep 13, 2021 77.98 78.21 78.78
77.67
1.37M 0% Sep 10, 2021 77.98 80.64 81.17
77.93
1.32M -2.66% Sep 9, 2021 80.11 78.61 80.58
77.73
2.13M 4.45% Sep 8, 2021 76.70 77.71 78.27
76.57
1.52M -1.43% Sep 7, 2021 77.81 78.01 81.92
77.60
2.48M -8.4% Sep 3, 2021 84.95 85.15 85.24
84.36
1.05M -0.23% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:March 1997 Employees:2,849 News
Cancer Concerns Are a New Worry for Gene Therapy. BioMarin Stock Is Falling. barrons.com Sep 9, 2021 2:15 pm
European Commission Approves BioMarins VOXZOGO® (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close finance.yahoo.com Sep 9, 2021 9:51 am
Stock Market News for Aug 30, 2021 finance.yahoo.com Sep 9, 2021 9:38 am
European Commission Approves BioMarin's VOXZOGO® (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close finance.yahoo.com Sep 9, 2021 9:01 am
BioMarin Plunges as FDA Puts Clinical Hold on a Gene Therapy Study finance.yahoo.com Sep 9, 2021 6:35 am
Biotech Stock Roundup: MRNA Submits Vaccine Data, BMRN Down on Clinical Hold & More finance.yahoo.com Sep 8, 2021 11:39 am
U.S. FDA Placed a Clinical Hold on BMN 307 Phearless Phase 1/2 Gene Therapy Study in Adults with PKU Based on Interim Pre-clinical Study Findings finance.yahoo.com Sep 6, 2021 2:00 am
BioMarin to Participate in Three Upcoming Virtual Investor Conferences finance.yahoo.com Aug 25, 2021 8:30 am
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings and Revenue Estimates finance.yahoo.com Aug 18, 2021 5:25 pm
BioMarin Announces Second Quarter 2021 Financial Results and Corporate Updates finance.yahoo.com Aug 18, 2021 4:03 pm
Analysts Estimate BioMarin Pharmaceutical (BMRN) to Report a Decline in Earnings: What to Look Out for finance.yahoo.com Aug 18, 2021 3:02 pm
BioMarins One-Year Data on Its Hemophilia Gene-Therapy Looked Good. Can It Win FDA Approval? barrons.com Aug 18, 2021 10:14 am
Gene-Therapy Firm Bluebird Bio Is Spinning Off Its Cancer Programs barrons.com Aug 18, 2021 8:11 am ANAB, TLRY, PFMT and BMRN among after hours movers seekingalpha.com Aug 18, 2021 6:33 am BioMarin Pharmaceutical (BMRN) surpasses second quarter revenue and revenue estimates illinoisnewstoday.com Aug 17, 2021 7:32 pm Analysts Anticipate 13% Upside For QQQJ nasdaq.com Aug 11, 2021 7:32 pm BioMarin Pharmaceutical Inc. (BMRN) Stock Declines -1.46% This Week; Should You Buy? investorsobserver.com Aug 4, 2021 7:32 pm
How Much Did BioMarin Pharmaceutical's(NASDAQ:BMRN ... simplywall.st Aug 4, 2021 7:32 pm BioMarin shares rise on Q2 earnings beat, FY topline forecast raise seekingalpha.com Jul 29, 2021 4:45 am BioMarin Pharmaceutical EPS beats by $0.18, beats on revenue seekingalpha.com Jul 29, 2021 4:10 am This company doesn't provide a dividend.
Key Persons CEO : Jean-Jacques Bienaime (May 2005–) Talk about BioMarin Pharmaceutical Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
